We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical’s experts Eugenia Radkova and Irina Petrova have published a new article devoted to the role of the Eurasian Economic Union for clinical trials.
This article describes the current status of the transition to unified rules for the registration of medicinal products and the main regulatory documents for conducting clinical trials in the EAEU region
Read the full article at Medical Writing Journal official website.[1]
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
